Elevated fibrinogen (Fg) concentration in blood is a high risk factor for many cardiovascular diseases. We hypothesize that Fg and its early degradation product, fragment D, may result in arterial constriction by binding endothelial intercellular adhesion molecule-1 (ICAM-1). The vasoconstriction induced by Fg and fragment D was studied in third-and second-order arterioles (3As and 2As, respectively) of Sprague-Dawley rat cremaster muscle in vivo, in aortic and femoral artery rings, and in the segments of first-order arterioles (1As) isolated from rat cremaster muscle. Intravascular infusion of Fg induced significant constriction of 3As and 2As (by 33.4 Ϯ 3.4 and 23.7 Ϯ 4.3%, respectively) in vivo and was abolished in the presence of the specific endothelin type A receptor blocker BQ-610. Fg and fragment D produced significant constriction of both aortic and femoral artery rings. (25), and stroke (9). Increased blood Fg concentration results in an increase in blood viscosity (20,23) and, therefore, an increase in blood flow shear stress (7). These in turn contribute to increased peripheral vascular resistance and lead to a reduction of blood flow in muscle, which exacerbates complications during hypertension (40). In addition, higher blood viscosity-induced increases in blood flow shear stress can activate endothelial cells (8, 38) and platelets (36). Endothelial cell activation results in expression of adhesion molecules, including intercellular adhesion molecule-1 (ICAM-1) (39). Fg is a ligand for ICAM-1 (18, 41), and as such, Fg binding to shear stressactivated platelets through platelet GPIIb/IIIa (34) may serve as a bridging mechanism for platelet adhesion to the endothelium (5). Therefore, elevated blood Fg content may lead to a higher predisposition for platelet thrombogenesis by triggering both platelet and endothelial activation mechanisms.Fg deposition onto the microvascular wall of mice after ischemia-reperfusion has been demonstrated elsewhere (26). This Fg deposition was partially reduced in an ICAM-1-mutant mouse, which suggests that Fg deposition at the vascular endothelium mainly occurs through endothelial ICAM-1. Hicks et al. (16) showed that Fg has a vasodilatory effect on the human saphenous vein. The authors suggested that this vasorelaxation could be a result of Fg binding to endothelial ICAM-1 and was induced by the expression of vasoactive mediators other than nitric oxide and prostacyclin.Various reports show the vasoactive effects of isolated peptides derived from plasmin digestion of fibrin and Fg in several vascular beds, including the lung (17), heart (27, 33), femoral artery (37), and mesenteric arteries (3). However, the mechanism of these effects still remains unclear. An attempt to study vasoconstriction of rat pulmonary artery rings induced by early digestion products of Fg failed to show any effect of these Fg fragments including fragment D (6). The effects of vascular constriction by Fg degradation products on the arterial rings were tested in the presence of 4 ϫ 10 Ϫ8 M phen...